2 studies found for:    3361530 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting CSL Behring Sclero XIII
Condition: Systemic Sclerosis
Interventions: Drug: Fibrogammin®P, coagulation factor XIII concentrate (Human);   Drug: 0.9% sodium chloride
2 Terminated Proof of Concept Trial of Gleevec (Imatinib) in Active Diffuse Scleroderma
Condition: Scleroderma
Interventions: Drug: Imatinib mesylate;   Other: Placebo

Indicates status has not been verified in more than two years